Financial News
Latest News about BIIB
Recent news which mentions BIIB
Could Biogen Acquire Axsome Therapeutics?
August 20, 2021
From Motley Fool
From InvestorPlace
From InvestorPlace
From Benzinga
From Benzinga
Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2
August 17, 2021
From Benzinga
From Benzinga
From InvestorPlace
From InvestorPlace
From Motley Fool
Why Is Biogen Pursuing a New Direction in Alzheimer's Research?
August 13, 2021
From Motley Fool
Is There Any Hope Left for This Alzheimer's Drug Developer?
August 13, 2021
Tickers
BIIB
From Motley Fool
How Much Should An Alzheimer's Drug Cost?
August 13, 2021
From Motley Fool
How to rein in pricey prescription costs on Medicare
August 13, 2021
Tickers
BIIB
Tags
BIIB
From MarketWatch
Cassava Sciences vs. Biogen
August 12, 2021
From Motley Fool
From Motley Fool
Biogen's New Alzheimer's Drug Turned Away By Veterans Affairs
August 12, 2021
From Benzinga
Is Axsome Therapeutics Stock Ready to Rebound?
August 12, 2021
From Motley Fool
From Motley Fool
3 Pharma Stocks to Buy in August
August 11, 2021
From Motley Fool
Will COVID-19 have long-term effects on the brain?
August 11, 2021
Tickers
BIIB
Tags
BIIB
From MarketWatch
Christina Applegate reveals she has MS, which costs patients more than $4 million over their lifetimes
August 10, 2021
From MarketWatch
Why Shares of Cassava Sciences Fell 18.6% in July
August 09, 2021
From Motley Fool
What to Do After Cassava Sciences Dropped Off a Cliff
August 09, 2021
From InvestorPlace
3 Things About Cassava Sciences That Smart Investors Know
August 05, 2021
From Motley Fool
Tickers
BIIB
From Motley Fool
Biogen: Does Aduhelm Make it the Next Dendreon?
July 30, 2021
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
